# ARKG (ARK Genomic Revolution ETF)

ARK · Thematic ETFs · data as of Sep 11, 2026

ARKG holds 33 stocks, and 96% of its weight is outside the S&P 500.

## Key facts

- ARKG, already in the S&P 500: 3.9%, as of Sep 11, 2026.
- ARKG, active share vs the S&P 500: 98.5%, as of Sep 11, 2026.
- ARKG, top ten holdings: 59.3%, as of Sep 11, 2026.
- ARKG, total return, 1 year: +74.0%, as of Sep 11, 2026.
- ARKG, net assets: $1.8bn (the issuer daily holdings, added up, as of Sep 11, 2026).
- ARKG, expense ratio: 0.75% (485BPOS XBRL, Nov 26, 2025).

## ARKG over each window to Sep 11, 2026

| Window | Total return | S&P 500 | Gap to S&P 500 | Gap to Nasdaq-100 |
| --- | --- | --- | --- | --- |
| 3 months | +36.1% | +3.3% | +32.8 pts | +36.9 pts |
| 6 months | +72.8% | +16.0% | +56.8 pts | +52.1 pts |
| 1 year | +74.0% | +17.5% | +56.5 pts | +51.0 pts |
| 3 years | +44.5% | +77.9% | −33.4 pts | −50.6 pts |
| Since launch | +142.3% | +361.8% | −219.5 pts | −529.3 pts |

## Every published field

| Field | Value | Source |
| --- | --- | --- |
| Theme | Biotech and genomics | ETFIQ, editorial |
| Launched | Oct 31, 2014 | ETFIQ |
| Already in the S&P 500, by weight | 3.9% | ETFIQ |
| Active share vs the S&P 500 | 98.5% | ETFIQ |
| Already in the Nasdaq-100, by weight | 0.0% | ETFIQ |
| Active share vs the Nasdaq-100 | 100.0% | ETFIQ |
| Top ten holdings weight | 59.3% | ETFIQ |
| Holdings | 33 | ETFIQ |
| Holdings as of | Sep 11, 2026 | the issuer’s daily file |
| Top holdings | 10X GENOMICS INC-CLASS A 10.3%, TWIST BIOSCIENCE CORP 8.3%, TEMPUS AI INC-CL A 7.7%, CRISPR THERAPEUTICS AG 5.9%, PERSONALIS INC 5.9%, ABSCI CORP 4.6%, GUARDANT HEALTH INC 4.4%, NATERA INC 4.3%, CAREDX INC 4.0%, ILLUMINA INC 4.0% | ETFIQ |
| Net assets | $1.8bn | the issuer daily holdings, added up, as of Sep 11, 2026 |
| Below its all-time high | −59.2% | ETFIQ |
| Expense ratio | 0.75% | 485BPOS XBRL, Nov 26, 2025 |
| Fee for the part that differs from the S&P 500, active expense ratio | 0.76% | ETFIQ |
| Closest funds by holdings overlap | GNOM 40%, WDNA 27%, ARKK 26%, HELX 25%, EKG 24% | ETFIQ |

## Questions

### How much of ARKG is in S&P 500 companies?

By its holdings published by its issuer for Sep 11, 2026, 4% of ARKG by weight is stocks the S&P 500 already holds. Its active share against the index is 98%, so that share is the part doing something different.

### What does ARKG hold?

33 positions as published by its issuer for Sep 11, 2026, with the top ten at 59% of the fund. The largest are 10X GENOMICS INC-CLASS A at 10.3%, TWIST BIOSCIENCE CORP at 8.3%, TEMPUS AI INC-CL A at 7.7%.

### Has ARKG beaten the S&P 500?

Over the year to Sep 11, 2026 ARKG returned +74.0% with distributions reinvested, against +17.5% for the S&P 500, so it finished ahead of the index by 56.5 points.

### What does ARKG cost?

The prospectus expense ratio is 0.75% a year. Because 98% of the fund differs from the S&P 500, the fee on that differing part works out at 0.76%.


## Cite this page

ETFIQ, ARKG, data as of Sep 11, 2026. https://etfiq.com/funds/arkg
Free to use with attribution; the underlying files are at https://etfiq.com/data/.

HTML: https://etfiq.com/funds/arkg  ·  JSON: https://etfiq.com/funds/arkg.json